Gartner, Inc. — Q1 2023 Form 10-Q
Reporting period: Three months ended March 31, 2023; comparisons are with the three months ended March 31, 2022. Gartner provides Research, Conferences and Consulting services. Unless stated otherwise, financial figures below are in U.S. dollars.
Financial results
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Revenue | $1.409 billion | $1.263 billion | +12% reported; +14% excluding foreign currency impact |
| Operating income | $408.0 million | $217.2 million | +88% |
| Net income | $295.8 million | $172.5 million | +71% |
| Diluted EPS | $3.68 | $2.08 | +$1.60 |
| Cash from operations | $164.7 million | $167.8 million | -$3.1 million |
- Revenue by segment: Research $1.217 billion, up 7%; Conferences $64.6 million, up 524%; Consulting $127.0 million, up 10%.
- Margins: Research gross contribution margin was 74% versus 75%; Conferences was 41% versus -28%; Consulting was 40% versus 44%. Cost of services and product development was 31% of revenue versus 30%, while SG&A was 47% versus 49%.
- Cash and liquidity: Cash and cash equivalents were $893.5 million at quarter-end. The company reported approximately $1.0 billion of available revolving-credit capacity and said liquidity was adequate for anticipated needs.
- Debt: Principal debt outstanding was $2.485 billion; the balance-sheet carrying amount, net of financing fees, was $2.461 billion. Weighted average effective borrowing rate was 5.03%. The company was in compliance with its credit-facility financial covenants.
- Balance sheet: Total assets were $7.379 billion and total liabilities were $6.906 billion at March 31, 2023. Current deferred revenue was $2.607 billion, up from $2.444 billion at year-end 2022.
Material changes and unusual items
- Operating income included a $139.3 million pretax gain from the February sale of TalentNeuron, a non-core Research business. Gartner received $158.7 million in cash, net of closing expenses, from the sale. The gain materially contributed to the year-over-year increase in operating income and net income.
- Q1 2023 also included $3.1 million of proceeds from 2020 event-cancellation insurance claims.
- Other expense/income included a $1.4 million loss on de-designated interest-rate swaps in Q1 2023, compared with a $29.9 million gain in Q1 2022. The effective tax rate rose to 22.4% from 19.8%; the filing attributes the increase primarily to the TalentNeuron sale.
- Investing cash flow was positive $137.6 million, compared with negative $17.3 million a year earlier, primarily reflecting TalentNeuron sale proceeds. Share repurchases used $106.9 million of cash, down from $451.1 million in Q1 2022.
- Q1 2023 operating cash flow was slightly lower despite higher operating income, primarily because deferred-revenue growth contributed less cash than in the prior-year period.
Outlook, management commentary and risks
- The filing provides no specific full-year 2023 revenue or earnings guidance. Management cautions that quarterly results may not indicate results for the remainder of the year; Consulting contract-optimization revenue may vary significantly.
- For contracts longer than one year, remaining performance obligations were approximately $5.3 billion at March 31, 2023. Gartner expected to recognize $2.4 billion during the rest of 2023, $2.1 billion in 2024, and $0.8 billion thereafter; these figures exclude qualifying contracts of one year or less.
- Research contract value was approximately $4.5 billion, up 10% year over year on a foreign-exchange-neutral basis. Client retention was 85% for Global Technology Sales and 89% for Global Business Sales; wallet retention was 104% and 110%, respectively. Management said lower incremental spending by existing clients contributed to lower wallet retention.
- Consulting backlog was $160.6 million, up 14% excluding foreign currency impact, but consultant utilization declined to 67% from 72%. Management cited higher personnel expense and headcount as factors in lower Consulting margins.
- Management identified macroeconomic and geopolitical uncertainty, inflation and personnel costs, interest-rate and foreign-currency movements, competition, employee retention, customer renewals and spending, cybersecurity, and conference timing among risks to future results. It said inflation had not materially affected operations to date, but cost increases may not be fully offset by pricing.
- Office-lease portfolio changes associated with a virtual-first hybrid-work transition led to $8.7 million of impairment charges in Q1 2023, down from $23.9 million a year earlier. Management said potential liabilities from ordinary-course litigation, beyond amounts accrued, were not expected to materially affect the company.
- The company reported no material changes to its previously disclosed risk factors. Management concluded disclosure controls were effective and reported no material change in internal control over financial reporting.
Important facts for investors to verify
- How much of earnings growth reflects recurring operations versus the $139.3 million TalentNeuron sale gain and other unusual items.
- Whether Research contract-value growth and retention metrics remain resilient, particularly given lower wallet retention.
- Whether Conferences revenue and contribution remain sustainable as event schedules and in-person attendance normalize.
- Whether Consulting utilization and contribution margins recover as headcount and backlog develop.
- Cash conversion, deferred-revenue trends, share repurchases, and debt-service capacity, including exposure to floating rates and foreign-currency movements.
- Potential outcomes and timing of post-closing adjustments on the TalentNeuron sale and resolution of tax audits and other contingencies.